ETHOSUXIMIDE
- Product NDC
- 64380-878
- 11-digit product format
- 643800878
- Labeler code
- 64380
- Product ID
- 64380-878_7388c216-3de2-4c6d-843c-f2e3b515a611
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ETHOSUXIMIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Strides Pharma Science Limited
- Application
- ANDA211928
- Marketing category
- ANDA
- Marketing start
- 2019-05-15
- Substance
- ETHOSUXIMIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ETHOSUXIMIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ETHOSUXIMIDE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5SEH9X1D1D |
| Rxcui | 197682 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 64380-878-06 | ETHOSUXIMIDE | 100 in 1 BOTTLE | CAPSULE | 100 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 64380-878 | ETHOSUXIMIDE CAPSULE [STRIDES PHARMA SCIENCE LIMITED] | 8 | Current NDC, Legacy NDC, 1 package rows | 20250313_a4dbc665-4db1-4d0a-9630-5cd200ec4c82.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64380-878-06 | 64380087806 | 100 CAPSULE in 1 BOTTLE (64380-878-06) | 100 capsule | 2019-05-15 | 0000-00-00 | No | No | Current |